Storer R D, Cartwright M E, Cook W O, Soper K A, Nichols W W
Department of Genetic Toxicology (WP45-311), Merck Research Laboratories, West Point, PA 19486.
Carcinogenesis. 1995 Feb;16(2):285-93. doi: 10.1093/carcin/16.2.285.
E mu-pim-1 transgenic mice, which overexpress the pim-1 oncogene in lymphoid tissues, have shown increased susceptibility to induction of T cell lymphomas by N-ethyl-N-nitrosourea, a direct-acting chemical carcinogen (Nature, 340, 61-63, 1989). We sought to further evaluate E mu-pim-1 transgenic mice as a potential test animal for a short-term carcinogenesis bioassay. We chose to test four genotoxic procarcinogens; 2-acetylaminofluorene (2-AAF), N-nitro-sodiethylamine (NDEA), 1,2-dichloroethane (1,2-DCE) and benzene (BEN). These compounds require metabolic activation and, with the exception of benzene, are not mouse lymphomagens. Compounds were administered by gavage daily for 38 (NDEA and 2-AAF) or 40 (BEN and 1,2-DCE) weeks to groups of 25-29 male and female PIM mice at 1 and 3 mg/kg for NDEA, 50 and 100 mg/kg for BEN, 25-100 mg/kg for 2-AAF and 100-300 mg/kg for 1,2-DCE. Small but statistically significant increases in the incidence of malignant lymphoma were seen for three of the four carcinogens tested; in high dose males treated with 2-AAF, high and low dose females treated with NDEA and high dose females treated with 1,2-DCE. Results for BEN, the only mouse lymphomagen tested, did not show a statistically significant increase in the incidence of malignant lymphomas in transgenic mice within the 40 week duration of the study. NDEA also produced a high incidence (> 70%) of hepatic hemangiosarcomas in both sexes at the low and high dose levels. These results demonstrate that over-expression of the pim-1 oncogene in lymphoid tissue can confer susceptibility of this tissue to chemical carcinogenesis by genotoxic procarcinogens. However, whereas potent genotoxic carcinogens produced only small increases in the incidence of lymphoma and since BEN, a mouse lymphomagen, was negative, PIM transgenic mice may lack sufficient sensitivity to established carcinogens to justify their routine use in a short-term carcinogenesis screening assay.
Eμ-pim-1转基因小鼠在淋巴组织中过表达pim-1癌基因,对直接作用的化学致癌物N-乙基-N-亚硝基脲诱导T细胞淋巴瘤的敏感性增加(《自然》,340卷,61 - 63页,1989年)。我们试图进一步评估Eμ-pim-1转基因小鼠作为短期致癌生物测定潜在实验动物的可能性。我们选择测试四种遗传毒性前致癌物:2-乙酰氨基芴(2-AAF)、N-亚硝基二乙胺(NDEA)、1,2-二氯乙烷(1,2-DCE)和苯(BEN)。这些化合物需要代谢激活,除苯外,都不是小鼠淋巴瘤致癌物。化合物通过灌胃给药,每天一次,持续38周(NDEA和2-AAF)或40周(BEN和1,2-DCE),给25 - 29只雄性和雌性PIM小鼠分组,NDEA剂量为1和3mg/kg,BEN为50和100mg/kg,2-AAF为25 - 100mg/kg,1,2-DCE为100 - 300mg/kg。在所测试的四种致癌物中的三种中,观察到恶性淋巴瘤发病率有小但具有统计学意义的增加;在高剂量2-AAF处理的雄性小鼠、高剂量和低剂量NDEA处理的雌性小鼠以及高剂量1,2-DCE处理的雌性小鼠中。在所测试的唯一小鼠淋巴瘤致癌物BEN的结果中,在研究的40周期间,转基因小鼠中恶性淋巴瘤的发病率没有显示出统计学上的显著增加。NDEA在低剂量和高剂量水平下,两性中肝血管肉瘤的发病率也很高(>70%)。这些结果表明,淋巴组织中pim-1癌基因的过表达可使该组织对遗传毒性前致癌物的化学致癌作用敏感。然而,虽然强效遗传毒性致癌物仅使淋巴瘤发病率有小的增加,并且由于小鼠淋巴瘤致癌物BEN呈阴性,PIM转基因小鼠可能对已确定的致癌物缺乏足够的敏感性,无法证明其在短期致癌筛选试验中的常规使用合理性。